This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23; On-demand experience Delivered September 28-30Boston Convention and Exhibition Center

Spyro Mousses, PhD
CEO at Systems Oncology


Dr. Mousses serves as the Co-Founder and Chief Executive Officer of Systems Oncology. He is widely recognized as a leading scientist in the application of genomics, RNAi, systems biology, and machine learning to improve and accelerate cancer drug discovery and development.  He has published more than 60 patents, scientific articles, and book chapters.  He served as Director of the Pharmaceutical Genomics Division at the Translational Genomics Research Institute (TGen), where he led 8 laboratories to develop more than 30 programs and collaborated with pharmaceutical partners to accelerate cancer drug development.  Prior to that, he served as Staff Scientist at the National Human Genome Research Institute (NHGRI), NIH, leading a program in cancer genome scanning and high throughput technology.


As a successful entrepreneur, Dr. Mousses has previously founded several biotech and IT companies, including Systems Medicine (acquired by Cell Therapeutics), MedTrust Online (acquired by Annai Systems), and Systems Imagination, which offers advanced cognitive computing technology to translate big data into biomedical insights.


Dr. Mousses received his PhD in Molecular Pathogenesis and Genetics of Cancer from the University of Toronto.  He can be reached by contacting his EA, Courtney Villani, at

Agenda Sessions

  • ROOM 205C: Arromer: Receptor Directed Delivery for Ultra-precise RNAi Multi-targeting